A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...

Manhattan-based dentist Dr. Sandip Sachar and obesity medicine specialist Dr. Meghan Garcia-Webb discuss the prevalence of ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

According to the Centers for Disease Control and Prevention, new data reveal that depression is becoming more prevalent in the United States.

I t’s hard to argue that the introduction of drugs like Ozempic has been anything short of revolutionary for people looking ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

Hansal Mehta's weight loss journey using Mounjaro sparked debate in India. AIIMS endocrinologist Dr. Yashdeep Gupta ...

CeCe Olisa is a trailblazing voice in inclusive health and beauty, dedicated to inspiring plus-size and Black women to ...

While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...

In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.

Since Ozempic hit the public consciousness as a weight-loss medication, one in eight Americans have tried it (or a version of it) to lose weight.

Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...